Inoue M - Search Results

1

Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1.

Nakajima M, Fujiki Y, Kyo S, Kanaya T, Nakamura M, Maida Y, Tanaka M, Inoue M, Yokoi T. Nakajima M, et al. Among authors: inoue m. J Clin Pharmacol. 2005 Jun;45(6):674-82. doi: 10.1177/0091270005276204. J Clin Pharmacol. 2005. PMID: 15901749 Clinical Trial.

2

Genetic polymorphisms of CYP2C8 in Japanese population.

Nakajima M, Fujiki Y, Noda K, Ohtsuka H, Ohkuni H, Kyo S, Inoue M, Kuroiwa Y, Yokoi T. Nakajima M, et al. Among authors: inoue m. Drug Metab Dispos. 2003 Jun;31(6):687-90. doi: 10.1124/dmd.31.6.687. Drug Metab Dispos. 2003. PMID: 12756196

3

Human CYP1B1 is regulated by estradiol via estrogen receptor.

Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T. Tsuchiya Y, et al. Among authors: inoue m. Cancer Res. 2004 May 1;64(9):3119-25. doi: 10.1158/0008-5472.can-04-0166. Cancer Res. 2004. PMID: 15126349

4

[Genetic diagnosis of endometrial cancer].

Kanaya T, Kyo S, Maida Y, Inoue M. Kanaya T, et al. Among authors: inoue m. Nihon Rinsho. 2004 Oct;62 Suppl 10:295-8. Nihon Rinsho. 2004. PMID: 15535254 Review. Japanese. No abstract available.

5

Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.

Kanaya T, Kyo S, Sakaguchi J, Maida Y, Nakamura M, Takakura M, Hashimoto M, Mizumoto Y, Inoue M. Kanaya T, et al. Among authors: inoue m. Am J Clin Pathol. 2005 Jul;124(1):89-96. doi: 10.1309/PAACLG8DXDK0X2B1. Am J Clin Pathol. 2005. PMID: 15923161

6

Human CYP2A6 is induced by estrogen via estrogen receptor.

Higashi E, Fukami T, Itoh M, Kyo S, Inoue M, Yokoi T, Nakajima M. Higashi E, et al. Among authors: inoue m. Drug Metab Dispos. 2007 Oct;35(10):1935-41. doi: 10.1124/dmd.107.016568. Epub 2007 Jul 23. Drug Metab Dispos. 2007. PMID: 17646279

7

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

Kyo S, Inoue M. Kyo S, et al. Among authors: inoue m. Oncogene. 2002 Jan 21;21(4):688-97. doi: 10.1038/sj.onc.1205163. Oncogene. 2002. PMID: 11850797 Review.

8

Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.

Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, Inoue M. Maida Y, et al. Among authors: inoue m. Oncogene. 2002 Jun 13;21(26):4071-9. doi: 10.1038/sj.onc.1205509. Oncogene. 2002. PMID: 12037663

9

2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.

Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, Takakura M, Nakamura M, Tanaka M, Inoue M. Yatabe N, et al. Among authors: inoue m. Cancer Gene Ther. 2002 Jul;9(7):624-30. doi: 10.1038/sj.cgt.7700479. Cancer Gene Ther. 2002. PMID: 12082463

10

How to inhibit telomerase activity for cancer therapy.

Kyo S, Inoue M. Kyo S, et al. Among authors: inoue m. Curr Med Chem Anticancer Agents. 2002 Sep;2(5):613-26. doi: 10.2174/1568011023353796. Curr Med Chem Anticancer Agents. 2002. PMID: 12678728 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,419 results

Search Page